The opinions expressed in the Webcasts are those of the speakers, presenters and Ortho-McNeil-Janssen Pharmaceuticals, Inc., and may not necessarily reflect the positions of the ASPE, or the Webhost. The appearance of the ASPE name and logo in the Webcasts does not constitute an endorsement of any products, services or information mentioned. The ASPE does not imply discrimination against other similar products or services.
Funding for ASPE and Webcast series was provided by PRICARA(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
All experts featured in the Webcasts and Nikki Stone are paid consultants for PRICARA(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
The PRICARA(R) Chronic Pain Barometer survey was conducted online from March 28-31, 2008, in partnership with HCD Research, Inc. on behalf of PRICARA(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., the marketer of ULTRAM(R) ER (tramadol HCl) extended release tablets, and involved 500 American adults, ages 18 and older, who self-identified as suffering from chronic pain.
About the American Society of Pain Educators (ASPE)
The ASPE is a 501(c)(3) non-profit professional organization dedicated to improving the standards of clinical pain practice. The goal of the ASPE is to promote optimal quality of life and physical functioning for pain sufferers by providing high-quality pain education training and continuing education programming for healthcare professionals.
The ASPE also provides educational opportunities for clinicians who
wish to become Certified Pain Educators (CPEs). CPEs serve as specialized
resources for pain management in their clinical settings, educating their
professional colleagues -- as well as patients, families and caregivers --
on ways to relieve pain by the safest means possible. As the Joint
Commission on Accreditation of Healthcare Organizations requires pain
management education in all of i
'/>"/>
| SOURCE ASPE: The American Society of Pain Educators Copyright©2008 PR Newswire. All rights reserved |